Frank Kanniess

2.1k total citations
55 papers, 1.5k citations indexed

About

Frank Kanniess is a scholar working on Physiology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Frank Kanniess has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Physiology, 44 papers in Pulmonary and Respiratory Medicine and 5 papers in General Health Professions. Recurrent topics in Frank Kanniess's work include Asthma and respiratory diseases (45 papers), Respiratory and Cough-Related Research (28 papers) and Inhalation and Respiratory Drug Delivery (22 papers). Frank Kanniess is often cited by papers focused on Asthma and respiratory diseases (45 papers), Respiratory and Cough-Related Research (28 papers) and Inhalation and Respiratory Drug Delivery (22 papers). Frank Kanniess collaborates with scholars based in Germany, United States and United Kingdom. Frank Kanniess's co-authors include H Magnussen, Bernhard Dahme, Kai Richter, Antje Kullowatz, Thomas Ritz, Rudolf A. Jörres, RA Jörres, Henrik Watz, James F. Donohue and Christian Taube and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Journal of Applied Physiology.

In The Last Decade

Frank Kanniess

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Kanniess Germany 22 947 806 234 147 118 55 1.5k
Władysław Pierzchała Poland 15 583 0.6× 384 0.5× 276 1.2× 89 0.6× 66 0.6× 76 940
Emmanouil Paraskakis Greece 19 595 0.6× 512 0.6× 46 0.2× 98 0.7× 78 0.7× 59 1.0k
T Kava Finland 16 2.5k 2.6× 2.0k 2.5× 192 0.8× 389 2.6× 157 1.3× 20 3.0k
Karen McKay Australia 25 926 1.0× 1.3k 1.7× 175 0.7× 122 0.8× 256 2.2× 67 2.1k
Magnus Lindén Sweden 8 247 0.3× 229 0.3× 81 0.3× 67 0.5× 55 0.5× 15 668
T R Bai Canada 21 1.0k 1.1× 888 1.1× 178 0.8× 129 0.9× 272 2.3× 28 1.7k
James A. McLean United States 10 1.1k 1.2× 858 1.1× 96 0.4× 488 3.3× 49 0.4× 22 1.6k
L. Hanssens Belgium 18 249 0.3× 291 0.4× 137 0.6× 191 1.3× 175 1.5× 63 1.2k
William Berger United States 13 918 1.0× 422 0.5× 88 0.4× 758 5.2× 24 0.2× 27 1.3k
Del Giacco Gs Italy 14 379 0.4× 110 0.1× 152 0.6× 250 1.7× 109 0.9× 80 896

Countries citing papers authored by Frank Kanniess

Since Specialization
Citations

This map shows the geographic impact of Frank Kanniess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kanniess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kanniess more than expected).

Fields of papers citing papers by Frank Kanniess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Kanniess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kanniess. The network helps show where Frank Kanniess may publish in the future.

Co-authorship network of co-authors of Frank Kanniess

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Kanniess. A scholar is included among the top collaborators of Frank Kanniess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Kanniess. Frank Kanniess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanniess, Frank, Marek Lommatzsch, Thomas Schultz, et al.. (2024). Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ). Pneumologie. 78(11). 912–921. 1 indexed citations
2.
Gillissen, Adrian, Christian Geßner, Felix Herth, et al.. (2018). Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial. Respiration. 97(4). 292–301. 6 indexed citations
3.
4.
Rennard, Stephen I., David C. Dale, James F. Donohue, et al.. (2015). CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 191(9). 1001–1011. 190 indexed citations
5.
Bardin, Philip G., Frank Kanniess, Gail M. Gauvreau, Dirk Bredenbröker, & Klaus F. Rabe. (2015). Roflumilast for asthma: Efficacy findings in mechanism of action studies. Pulmonary Pharmacology & Therapeutics. 35. S4–S10. 41 indexed citations
6.
Bostantzoglou, Clementine, et al.. (2015). Clinical asthma phenotypes in the real world: opportunities and challenges. Breathe. 11(3). 186–193. 27 indexed citations
7.
Pedersen, Frauke, Olaf Holz, Frank Kanniess, et al.. (2014). Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma. BMC Research Notes. 7(1). 925–925. 2 indexed citations
8.
Kanniess, Frank, Mario Scuri, Stefano Vezzoli, Catherine Francisco, & Stefano Petruzzelli. (2014). Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler®) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial. Pulmonary Pharmacology & Therapeutics. 30. 121–127. 23 indexed citations
9.
Beeh, Kai-Michael, Frank Kanniess, Frank Wagner, et al.. (2013). The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. Journal of Allergy and Clinical Immunology. 131(3). 866–874. 141 indexed citations
10.
Ritz, Thomas, Antje Kullowatz, Michaël Goldman, et al.. (2010). Emotional reactivity of the airways in asthma: Consistency across emotion-induction techniques and emotional qualities. Biological Psychology. 84(1). 74–81. 8 indexed citations
11.
Berge, Maarten van den, Syed Hasan Arshad, Philip W. Ind, et al.. (2009). Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering. Respiratory Medicine. 103(8). 1216–1223. 8 indexed citations
12.
Joos, Guy, Vanessa Schelfhout, Ruben Pauwels, et al.. (2009). Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients. Respiratory Medicine. 104(6). 865–872. 27 indexed citations
13.
Ritz, Thomas, Antje Kullowatz, Frank Kanniess, Bernhard Dahme, & H Magnussen. (2008). Perceived triggers of asthma: Evaluation of a German version of the Asthma Trigger Inventory. Respiratory Medicine. 102(3). 390–398. 30 indexed citations
14.
Kanniess, Frank, et al.. (2007). Neue pharmakologische Ansätze in der Therapie der COPD. Pneumologie. 61(6). 365–373. 1 indexed citations
15.
Derom, Eric, et al.. (2007). Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma. European Respiratory Journal. 29(5). 871–878. 49 indexed citations
16.
Kullowatz, Antje, Sibylle Petersen, Frank Kanniess, & Thomas Ritz. (2005). Non-invasive measurement of airway inflammation using exhaled nitric oxide: Temporal stability and relationship with climate, air pollution and lung function. Psychosomatic Medicine. 1 indexed citations
17.
Richter, Kai, et al.. (2005). Comparison of the Oropharyngeal Deposition of Inhaled Ciclesonide and Fluticasone Propionate in Patients With Asthma. The Journal of Clinical Pharmacology. 45(2). 146–152. 69 indexed citations
18.
Holz, Olaf, Lutz Welker, Frank Kanniess, et al.. (2004). Direct measurement of BDP and 17-BMP in bronchial and peripheral lung tissue after inhalation of HFA- vs CFC-driven aerosols. Pulmonary Pharmacology & Therapeutics. 17(4). 233–238. 11 indexed citations
19.
Kanniess, Frank, et al.. (2002). Montelukastversusfluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma. European Respiratory Journal. 20(4). 853–858. 44 indexed citations
20.
Kanniess, Frank, et al.. (2001). In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respiratory Medicine. 95(2). 115–121. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Władysław Pierzchała Breakdown of academic impact, for papers by Emmanouil Paraskakis Breakdown of academic impact, for papers by T Kava Breakdown of academic impact, for papers by Karen McKay Breakdown of academic impact, for papers by Magnus Lindén Breakdown of academic impact, for papers by T R Bai Breakdown of academic impact, for papers by James A. McLean Breakdown of academic impact, for papers by L. Hanssens Breakdown of academic impact, for papers by William Berger Breakdown of academic impact, for papers by Del Giacco Gs
Rankless by CCL
2026